Press Release 19 April, 2023
Realheart's planned Annual General Meeting (AGM) will be moved from May 26 to June 16, 2023. The reason for this is that the company intends to arrange a physical meeting in Västerås and the previously communicated date conflicts with other planned activities. In connection with this, the publication of the annual report for 2022 is also moved forward to May 26, i.e. three weeks before the date of the meeting, in accordance with current regulations.
Notice of the AGM will be sent out as usual four weeks before the meeting, i.e. on May 19.
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.Realheart Moves the Date of the Annual General Meeting and Publication of the Annual Report for 2022 (PDF)